Acasti Pharma, Inc (ACST): Acasti Pharma to Present CaPre Omega-3 B...

Reply Private New

Next 10 Prev Next

I.B.Broke

Send PM Follow Ignore

Followers	10
Posts	500
Boards Moderated	0
Alias Born	09/04/2014

I.B.Broke

Re: None

Friday, 04/14/2017 9:12:29 PM

Friday, April 14, 2017 9:12:29 PM

Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association Scientific Sessions

http://www.acastipharma.com/wp-content/uploads/Acasti-NLA-PR-FINAL.11April2017.pdf

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ACST News

Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 01:00:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 12:30:29 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 01:00:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:30:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:08:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:08:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:05:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 12:30:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 12:30:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:30:18 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/16/2023 08:31:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:09 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/06/2023 08:30:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 11:46:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 12:10:09 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 07:54:48 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/25/2023 09:01:03 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/25/2023 08:21:04 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/25/2023 08:15:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 11:31:17 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 11:15:38 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 09:30:28 PM

More ACST News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover